Orexo AB (publ)
STO: ORX.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nikolaj Sorensen
- Employees
- 110
- Headquarters
- Uppsala, Sweden
- IPO year
- 2005
- Market cap
- SEK 649.1M
- Website
- https://www.orexo.com
Loading ORX…
Loading profile data…Frequently asked questions about ORX
What does Orexo AB (publ) (ORX.ST) do?
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment o...
Where does ORX.ST trade?
Orexo AB (publ) (ORX.ST) trades on the Stockholm Stock Exchange.
What sector is ORX.ST in?
Orexo AB (publ) (ORX.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Orexo AB (publ)?
Nikolaj Sorensen is the chief executive officer of Orexo AB (publ) (ORX.ST).
Where is Orexo AB (publ) headquartered?
Orexo AB (publ) is headquartered in Sweden.
Does ORX.ST pay a dividend?
Orexo AB (publ) (ORX.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ORX.ST go public?
Orexo AB (publ) (ORX.ST) completed its initial public offering in 2005.